Markets:

Overview

News

Currencies

International

Treasuries

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

24.00 -1.93 (-7.44%)

Streaming Delayed Price Updated: 2:37 PM EDT, Apr 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Legend Biotech Corporation - American Depositary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Why Shares of Geron Are Up 30% This Week ↗

April 20, 2023

The company's CEO was scheduled to speak at a virtual conference on Thursday.

Via The Motley Fool

Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names ↗

April 20, 2023

Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is...

Via Benzinga

7 Biotech Stocks That Could Cure Your Portfolio Woes ↗

April 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 19, 2023

Via Benzinga

The Latest Analyst Ratings for Legend Biotech ↗

April 18, 2023

Via Benzinga

Where Legend Biotech Stands With Analysts ↗

March 29, 2023

Via Benzinga

The Latest Analyst Ratings for Legend Biotech ↗

January 24, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Why Shares of Legend Biotech Jumped Wednesday ↗

April 19, 2023

A leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.

Via The Motley Fool

Legend Biotech Corp. (NASDAQ: LEGN) Leading the Way in Wednesday Trading Based on Percentage Gain

April 19, 2023

Via Investor Brand Network

4 Analysts Have This to Say About Legend Biotech ↗

December 20, 2022

Via Benzinga

Legend Biotech Breaks Out After Leaked Documents Show Big CAR-T Benefit ↗

April 19, 2023

The company could have the best-in-class CAR-T drug for multiple myeloma patients.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

Western Alliance Bancorporation, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

April 19, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. Western Alliance Bancorporation (NYSE: WAL) shares jumped 15.4% to $37.50...

Via Benzinga

Legend Biotech Announces Appointment of Chief Medical Officer

April 11, 2023

From Legend Biotech

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

April 07, 2023

Via Benzinga

Legend Biotech Establishes Strategic Advisory Board

April 03, 2023

From Legend Biotech

Via Business Wire

Legend Biotech Reports Full-Year 2022 Results and Recent Highlights

March 30, 2023

From Legend Biotech

Via Business Wire

7 Biotech Stocks to Buy for Breakthrough Treatments and Cures ↗

March 29, 2023

For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 ↗

March 29, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023 ↗

March 24, 2023

Via Benzinga

Legend Biotech Announces Participation in Upcoming Investor Conferences

February 24, 2023

From Legend Biotech

Via Business Wire

Legend Biotech Regains Compliance with NASDAQ Listing Rule 5250(c)(2)

February 21, 2023

From Legend Biotech

Via Business Wire

Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug ↗

January 28, 2023

Shanghai’s HutchMed out-licensed global rights for a colorectal cancer therapy to Japan’s Takeda in a deal worth up to $1.13 billion, including $400 million upfront. In addition to the $1.13 billion,...

Via Talk Markets

Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

January 27, 2023

From Legend Biotech

Via Business Wire

Legend Biotech to Participate in the 41st Annual JP Morgan Healthcare Conference

January 03, 2023

From Legend Biotech

Via Business Wire

Legend Biotech Announces Acceptance of Its New Drug Application for Ciltacabtagene Autoleucel (Cilta-Cel) in China

January 02, 2023

From Legend Biotech

Via Business Wire

Gracell Biotech Stock Has Over 100% Upside On Next-Gen CAR-T Platforms, Analyst Claims ↗

December 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.